Kataoka K, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Iwai-Kanai E, Kawamura T, Hirai T, Kita T, Nohara R: LOX-1 Pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 300:656-660
Ashida N, Takechi H, Kita T, Arai H: Vortex-mediated mechanical stress induces integrin-dependent cell adhesion mediated by inositol-1, 4, 5 triphosphate-sensitive Ca2+ release in THP-1 cells. J Biol Chem 278: 9327-9331
Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and the J-LIT Study Group: Sustained Reduction of Serum Cholesterol in Low-Dose 6-Year Simvastatin Treatment With Minimum Side Effects in 51, 321 Japanese Hypercholesterolemic Patients. -Implication of the J-LIT Study, a Large Scale Nationwide Cohort Study. Circ. J. 67: 287-294
Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278: 18229-34
Tanaka M, Matsubayashi K, Yokode M, Kita T: Donepezil and athetosis in an elderly patient with Alzheimer’s disease. J. Am. Geriatr. Soc. 51(6): 889-890
Tabuchi A, Yoshioka A, Higashi T, Shirakawa R, Nishioka H, Kita T, Horiuchi H: Direct demonstration of involvement of protein kinase Calpha in the Ca2+-induced platelet aggregation. J.Biol.Chem. 18; 278(29): 26374-26379
Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y: A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology. 38(2): 403-12
Abe M, Hasegawa K, Wada H, Morimoto T, Yanazume T, Kawamura T, Hirai M, Furukawa Y, Kita T: GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 23(3): 404-10
Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol. 23(10): 3593-606
Iwai-Kanai E, Hasegawa K, Adachi S, Fujita M, Akao M, Kawamura T, Kita T: Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis. Biochem Biophys Res Commun.305(4): 898-903
Watanabe T, Katsukura H, Shirai Y, Yamori M, Chiba T, Kita T, Wakatsuki Y: Helper CD4+ T cells for IgE response to a dietary antigen develop in the liver. J Allergy Clin Immunol. 111(6): 1375-85
Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol. 171(4): 1647-51
Itoh T, Yoshida M, Chiba T, Kita T, Wakatsuki Y: A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis. Helicobacter. 8(4): 268-78
Yamada SI, Takechi H, Kanchiku I, Kita T, Kato N: Small conductance Ca2+ -dependent K+ channels are the target of spike-induced Ca2+ release in a feedback regulation of pyramidal cell excitability. J Neurophysiol.
Shirakawa R, Higashi T, Tabuchi A, Yoshioka A, Nishioka H, Fukuda M, Kita T, Horiuchi H: Munc13-4 is a GTP-Rab27 binding protein regulating dense-core granule secretion in platelets. J Biol Chem
Sato Y, Taniguchi R, Yamada T, Matsumori A: Measurements of serum cardiac troponin T in patients with heart failure. Am. Heart J. 145(4): 18-19.
Nishio R, Shioi T, Sasayama S, Matsumori A: Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J. Am. Coll. Cardiol. 41(2): 340-345.
Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell Biol. 10: 3593-3606.
Matsumori A: The 1st Candesartan Asian Advisors Meeting ― Highlight Report―Treatment of heart failure- A new efficacy parameter and future perspective. Medical Tribune Topic News Report.
Kasuno K, Ono T, Matsumori A, Nogaki F, Kusano H, Watanabe H, Yodoi J, Muso E: Hepatitis C virus- associated tubulointerstitial injury. Am. J. Kidney Dis. 41(4): 767-775.
Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A: Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. (letter) Heart 89: 659-660.
Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, Kimoto Y, Sakuma I, Nonogi H, Matsumori A, Yamamoto Y: Men’s Health Study -Epidemiology of erectile dysfunction and cardiovascular disease- Circulation J. 67: 656-659.
Kitaura-Inenaga K, Hara M, Higuchi H, Yamamoto K, Yamaki A, Ono K, Nakano A, Kinoshita M, Sasayama S, Matsumori A: Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ J. 67: 881-884.
Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T: Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9: 1477-1483.
Yamamoto K, Shioi T, Uchiyama K, Miyamoto T, Sasayama S, Matsumori A: Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J. Am. Coll. Cardiol. 42: 2000-2006.
Matsumori A: Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur. J. Heart Fail. 5: 669-677.
Kakio T, Matsumori A, Ohashi N, Yamada T, Nobuhara M, Saito T, Kawamoto A, Taguchi A, Morita Y, Takahashi M, Sasayama S: The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3 mm in stent diameter. Int. Med. 42(11): 1084-1089.
Ito H, Nakano A, Kinoshita M, Matsumori A: Pioglitazone, a peroxisome proliferator- activaed receptor-g agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab. Invest. 83(12): 1715-1721.
Matsumori A: 1. Introductory chapter, In “Cardiomyopathies and heart failure. Biomolecular, infections and immune mechanisms” (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp1-15.
Matsumori A, Ohashi N, Ito H, Furukawa Y, Hasegawa K, Sasayama S, Naruse T, Inoko H, and co-inovestigators: Genes of the major histocompability complex class II influence the phenotype of cardiomyopathies associated with hepatitis C virus infection, In “Cardiomyopathies and heart failure”,(Ed, Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp515-521.
Hara M, Ono K, Sasayama S, Matsumori A: The key role of mast cells in the evolution to congestive heart failure, In “Cardiomyopathies and heart failure”, (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp213-228.
Njenga MK, Matsumori A, Gwathmey JK: Large animal model of viral myocarditis, In “Cardiomyopathies and heart failure”, (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp301-324.
Sato Y, Yamada T, Matsumori A: Hepatitis C virus and cardiomyopathy, In “Cardiomyopathies and heart failure”, (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp325-339.
Noguchi T, Kihara Y, Begin KJ, Gorga JA, Palmiter KA, LeWinter MM, VanBuren P: Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart: amelioration by endothelin blockade. Circulation 107:630-635
Izumi T, Kihara Y, Inagaki K, Iwanaga Y, Yoneda T, Onozawa Y, Sasayama S: Re-induction of T-type calcium channels by endothelin-1 in failing hearts in vivo and adult rat ventricular myocytes in vitro. Circulation 108:2530-2535
Yoneda T, Kihara Y, Takenaka H, Onozawa Y, Sarai N, Kita T: RhoA Expression is not a Critical Determinant in Hypertension Evolution in Salt-Sensitive Dahl Rats. Med. Sci. Monit. 9:BR399-BR402
Kume N, Kita T: New scavenger receptors and their functions in atherogenesis. Current Atherosclerosis Reports vol. 4: 253-257
Kume N, Kita T: Roles of oxidized low-density lipoprotein and its receptors in the pathogenesis of atherosclerotic diseases. Geriatrics Gerontology International vol. 2: 172-178
Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. vol. 171: 1647-1651
Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukoc. Biol. vol. 75: 267-274
Yamauchi R, Tanaka M, Kume N, Minami M, Kawamoto T, Togi K, Shimaoka T, Takahashi S, Yamaguchi J, Nishina T, Kitaichi M, Komeda M, Manabe T, Yonehara S, Kita T: Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol. vol. 24: 282-287
Kume N, Kita T : Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1, and its implication in atherosclerotic plaque rupture. Circ. Res. vol. 94: 269-270
Yui Y: Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japanese Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]), Am. J. Cardiol.92: 789-793.
Yui Y: Blood Pressure Lowering Treatment Trialist’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 362: 1527-1535.
Miwa K, Kishimoto C, Nakamura H, Makita T, Okuda N, Taniguchi A, Shioji K, Yodoi J, Sasayama S: Increased oxidative with elevated serum thioredoxin level patients with coronary spastic angina. Clin. Cardiol. 26:177-181.
Miyamoto M, Kishimoto C, Shioji K, Lee DJ, Shimizu H, Ueda T, Yodoi J: Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J. 67: 116-118.
Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Fujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int. J. Cardiol. 91: 173-178.
Yuan Z, Kishimoto C, Sano H, Shioji K, Xu Y, Yokode M: Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. Am. J. Physiol. 285: H899-H906.
Yuan Z, Kishimoto C, Shioji K: Beneficial effects of low-dose benedipine in acute autoimmune myocarditis. Suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circ. J. 67: 545-550.
Yuan Z, Shioji K, Kishimoto C: Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis. Exp & Clin. Cardiol. 8: 13-16.
Kishimoto C, Tomioka N, Nakayama Y, Miyamoto M: Anti-oxidant effects of coenzyme Q10 on experimental viral myocarditis in mice. J. Cardiovasc. Pharmacol. 42:588-592. Kishimoto C, Hiraoka Y, Takamatsu N, Takada H, Kamiya H, Ochiai H: An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency (SCID) mouse. Cardiovasc. Res. 60:397-403.
Yuan Z, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z: Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis. Cardiovasc. Res. 59:685-694.
Nimata M, Kishimoto C, Shioji K, Ishizaki K, Kitaguchi S, Hashimoto T, Nagata N, Kawai C: Expression of thioredoxin in the endomyocardial biopsy samples in patients with cardiomyopathies. Mol. Cell. Biochem. 248:193-196.
Makino T, Ono T, Matsuyama K, Nogaki F, Miyawaki S, Honda G, Muso E: Suppressive effects of Perilla frutescens on IgA nephropathy in HIGA mice. Nephrol. Dial. Transplant. 18: 484-490.
Kasuno K, Ono T, Matsumori A, Nogaki F, Kusano H, Watanabe H, Yodoi J, Muso E: Hepatitis C virus-associated tubulointerstitial injury. Am. J. Kidney. Dis. 41(4) 767-775.
Hamada K, Nagai S, Ono T, Muso E, Nagao T, Shigematsu M, Izumi T, Mishima M: Sarcoidosis complicated with IgA nephropathy. Sarcoidosis Vasc. Diffuse. Lung Dis. 20: 69-73.
Handa T, Ono T, Watanabe H, Takeda T, Muso E, Kita T: Glomerulonephritis induced by Methicillin-sensitive Staphylococcus aureus infection. Clin. Exp. Nephrol. 7: 247-249.
Kasuno K, Nakamura H, Ono T, Muso E, Yodoi J: Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia-reperfusion injury. Kidney Int. 64: 1273-1282.
Kataoka K, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Iwai-Kanai E, Kawamura T, Hirai T, Kita T, Nohara R: LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res Commun. 300: 656-660.
Abe M, Hasegawa K, Wada H, Morimoto T, Yanazume T, Kawamura T, Hirai M, Furukawa Y, Kita T: GATA-6 is involved in PPAR?-mediated activation of differentiated phenotyoe in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol.23: 404-410.
Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell. Biol.23: 3593-3606.
Iwai-Kanai E, Hasegawa K, Adachi S, Fujita M, Akao M, Kawamura T, Kita T: Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis. Biochem. Biophys. Res. Commun.305: 898-903.
Yanazume T, Morimoto T, Wada H, Kawamura T, Hasegawa K: Biological role of p300 in cardiac myocytes. Mol. Cell. Biochem.248: 115-119.
Sato Y, Taniguchi R, Yamada T, Matsumori A: Measurements of serum cardiac troponin T in patients with heart failure. Am. Heart J.: 145: e18
Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y: Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 89:659-60.
Goishi K, Lee P, Davidson AJ, Nishi E, Zon LI and Klagsbrun M: Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mech Dev. 120: 811-822.
Nishi E, Higashiyama S and Klagsbrun M: Heparin-binding epidermal growth factor-like growth factor. In Encyclopedia of Hormones. Ed.by Henry HL and Norman AW Academic Press, San Diego, 2: 235-241
Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M: New ELISA system for myeloid-related protein complex (MRP 8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin. Chem. 49(4): 594-600.
Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, Tabata Y: Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart and Vessels 18:93-99.
Fujita M, Mizuno K, Ho M, Tsukahara R, Miyamoto A, Miki O, Ishii K, Miwa K: Sarpogrelate treatment reduces restenosis after coronary stenting. Am. Heart J. 145(3): e16.
Iwakura A, Tabata Y, Koyama T, Doi K, Nishimura K, Kataoka K, Fujita M, Komeda M: Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J. Thorac. Cardiovasc. Surg. 126(4): 1113-1120.
Fujita M: Angiogenic therapy by coronary collateral recruitment and arteriogenesis. In Myocardial Ischemia and Preconditioning, ed. by Dhalla NS, Takeda N, Singh M, Lukas A. Kluwer Academic Publishers, Boston, 13-22.